We are live on ! Find out more
Seth Klarman

Seth Klarman Baupost Group

AUM $5.05B Turnover 24%
1-Year Est. Return 13.05%
 

Seth Klarman is the founder and CEO of the Baupost Group, one of the most respected value-oriented investment firms. He is the author of Margin of Safety and is known for patient, opportunistic capital allocation across equities, credit, and special situations. Klarman’s approach emphasizes downside protection, cash when opportunities are scarce, and independent thinking when markets become crowded.

This Fund
S&P 500
This Quarter Est. Return
-1.52%
1 Year Est. Return
+13.05%
3 Year Est. Return
+47.21%
5 Year Est. Return
+23.41%
10 Year Est. Return
+137.34%
AUM
$5.09B
AUM Growth
-$650M
Cap. Flow
-$392M
Cap. Flow %
-7.7%
Top 10 Hldgs %
83.13%
Holding
31
New
4
Increased
7
Reduced
5
Closed
4
Avg Time Held
0.8 years
Top 10 Avg Time Held
0.8 years
Top 20 Avg Time Held
0.7 years

Sector Composition

Rank Sector Weight
1 Energy 32.61%
2 Technology 30.85%
3 Healthcare 17.83%
4 Consumer Discretionary 10.27%
5 Miscellaneous 2.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
LNG icon
1
Cheniere Energy
LNG
$60.2B
$972M 19.09%
13,807,230
+2,608,200
+23% +$184M
2014 Q1
3 quarters
VSAT icon
2
Viasat
VSAT
$7.83B
$727M 14.28%
11,533,137
– –
2013 Q2
6 quarters
MU icon
3
Micron Technology
MU
$673B
$690M 13.55%
19,706,035
-31,949,399
-62% -$1.06B
2013 Q2
6 quarters
EBAY icon
4
eBay
EBAY
$50.7B
$523M 10.27%
22,132,440
+7,646,664
+53% +$174M
2014 Q2
2 quarters
AR icon
5
Antero Resources
AR
$11B
$318M 6.26%
7,847,831
+5,088,321
+184% +$244M
2014 Q3
1 quarter
INVA icon
6
Innoviva
INVA
$1.31B
$280M 5.51%
19,815,983
– –
2013 Q2
6 quarters
KERX
7
DELISTED
Keryx Biopharmaceuticals
KERX
$259M 5.09%
18,300,000
– –
2014 Q1
3 quarters
PBF icon
8
PBF Energy
PBF
$7.46B
$231M 4.53%
8,663,114
+1,517,696
+21% +$39.5M
2013 Q3
5 quarters
VRTV
9
DELISTED
Veritiv
VRTV
$120M 2.36%
2,314,193
-48,692
-2% -$2.34M
2014 Q3
1 quarter
FWP
10
DELISTED
Forward Pharma
FWP
$112M 2.2%
+766,757
New +$111M
2014 Q4
0 quarters
TBPH icon
11
DELISTED
Theravance Biopharma
TBPH
$90.4M 1.78%
6,061,228
– –
2014 Q2
2 quarters
ONIT icon
12
Onity Group
ONIT
$206M
$90.1M 1.77%
397,803
-68,977
-15% -$22.5M
2014 Q3
1 quarter
C.WS.A icon
13
DELISTED
Citigroup
C.WS.A
$89.3M 1.75%
102,673,007
-19,900,000
-16% -$18.1M
2013 Q2
6 quarters
SEMI icon
14
DELISTED
SunEdison Semiconductor
SEMI
$77M 1.51%
4,145,379
– –
2014 Q2
2 quarters
IMOS icon
15
ChipMOS TECHNOLOGIES
IMOS
$1.24B
$76.6M 1.5%
2,979,654
– –
2013 Q2
6 quarters
BXE
16
DELISTED
Bellatrix Exploration
BXE
$65.9M 1.29%
+3,620,743
New +$80.5M
2014 Q4
0 quarters
NG icon
17
NovaGold Resources
NG
$2.05B
$64M 1.26%
21,688,300
– –
2013 Q2
6 quarters
PRTK
18
DELISTED
Paratek Pharmaceuticals
PRTK
$62.1M 1.22%
+1,735,218
New +$41.4M
2014 Q4
0 quarters
KOS icon
19
Kosmos Energy
KOS
$983M
$60.8M 1.19%
7,242,354
+2,492,354
+52% +$22.2M
2014 Q2
2 quarters
ATRA icon
20
Atara Biotherapeutics
ATRA
$64.5M
$59.1M 1.16%
+99,837
New +$61M
2014 Q4
0 quarters
ELOS
21
DELISTED
Syneron Medical
ELOS
$22.5M 0.44%
2,416,310
-578,300
-19% -$5.58M
2013 Q2
6 quarters
KIN
22
DELISTED
Kindred Biosciences
KIN
$22.5M 0.44%
3,013,848
– –
2013 Q4
4 quarters
AIG.WS icon
23
DELISTED
AIG Warrants
AIG.WS
$21.9M 0.43%
889,387
+100,389
+13% +$2.4M
2013 Q2
6 quarters
ALDW
24
DELISTED
Alon USA Partners LP
ALDW
$12.3M 0.24%
954,188
+625,000
+190% +$10.5M
2013 Q4
4 quarters
AOI
25
DELISTED
Alliance One International
AOI
$10.1M 0.2%
638,364
– –
2013 Q2
6 quarters

Similar funds

Seth Klarman's Q4 2014 Portfolio in Review

As of Q4 2014, Seth Klarman held 31 positions worth $5.09B, down 11% from $5.74B the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Seth Klarman withdrew a net $392M in Q4 2014, closing 4 positions and reducing 5 holdings. Its most notable exit was RF Micro Devices, an estimated $113M position sold in full.

By sector, the portfolio is most concentrated in Energy at 33% of assets, up from 22% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Seth Klarman opened a new position in Forward Pharma worth $112M.

  • Seth Klarman's largest Q4 2014 buy was Forward Pharma: 766,757 shares worth $112M.
  • Seth Klarman added most to Antero Resources in Q4 2014, an estimated $244M increase.
  • Seth Klarman's biggest Q4 2014 reduction was Micron Technology, cutting an estimated $1.06B.
  • Seth Klarman fully exited RF Micro Devices in Q4 2014, selling an estimated $113M.
  • Seth Klarman's ten largest holdings make up 83% of its $5.09B portfolio in Q4 2014.
  • Seth Klarman opened 4 new positions and closed 4 in Q4 2014.
  • Seth Klarman's portfolio value fell 11% quarter-over-quarter to $5.09B.

Based on Baupost Group's 13F filing for Q4 2014, filed 13 Feb 2015.